HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 283, Issue 17, 11677-11688, April 25, 2008

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 283/17/11677    most recent M709516200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Leskovar, A. Articles by Reinstein, J. PubMed PubMed Citation Articles by Leskovar, A. Articles by Reinstein, J. Social Bookmarking                      What's this?

The ATPase Cycle of the Mitochondrial Hsp90 Analog Trap1^*

Adriane Leskovar, Harald Wegele¹, Nicolas D. Werbeck, Johannes Buchner, and Jochen Reinstein²

From the Department of Biomolecular Mechanisms, Max-Planck-Institute for Medical Research, Jahnstrasse 29, Heidelberg 69120 and Department of Chemie, Technische Universität München, Lichtenbergstrasse 4, Garching 85747, Germany

Hsp90 is an ATP-dependent molecular chaperone whose mechanism is not yet understood in detail. Here, we present the first ATPase cycle for the mitochondrial member of the Hsp90 family called Trap1 (tumor necrosis factor receptor-associated protein 1). Using biochemical, thermodynamic, and rapid kinetic methods we dissected the kinetics of the nucleotide-regulated rearrangements between the open and the closed conformations. Surprisingly, upon ATP binding, Trap1 shifts predominantly to the closed conformation (70%), but, unlike cytosolic Hsp90 from yeast, this process is rather slow at 0.076 s^-1. Because reopening (0.034 s^-1) is about ten times faster than hydrolysis (k_hyd = 0.0039 s^-1), which is the rate-limiting step, Trap1 is not able to commit ATP to hydrolysis. The proposed ATPase cycle was further scrutinized by a global fitting procedure that utilizes all relevant experimental data simultaneously. This analysis corroborates our model of a two-step binding mechanism of ATP followed by irreversible ATP hydrolysis and a one-step product (ADP) release.

Received for publication, November 20, 2007 , and in revised form, February 5, 2008.

^* This work was supported by the Max-Planck-Gesellschaft and the Deutsche Forschungsgemeinschaft (DFG) (Grant RE 1212/1-2 to J. R.), fellowships from the Fonds der chemischen Industrie and the Studienstiftung des Deutschen Volkes (to H. W.), and DFG (Grant SFB 594) and the Fonds der chemischen Industrie (to J. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1-S9.

¹ Pharma Development, Roche Diagnostics, Nonnenwald 2, Penzberg 82377, Germany.

² To whom correspondence should be addressed: Tel.: 49-6221-486502; Fax: 49-6221-486585; E-mail: Jochen.Reinstein{at}mpimf-heidelberg.mpg.de.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Richter, J. Soroka, L. Skalniak, A. Leskovar, M. Hessling, J. Reinstein, and J. Buchner Conserved Conformational Changes in the ATPase Cycle of Human Hsp90 J. Biol. Chem., June 27, 2008; 283(26): 17757 - 17765. [Abstract] [Full Text] [PDF]